Sarah Young, PhD
(919) 549-0445 Main Office
Log in to view additional contact information.
Diagnostic Lab Director
Centers & Contact Information
Sarah Young is an Assistant Professor in the Department of Pediatrics, in the Duke School of Medicine, and Co-Director of the Duke Biochemical Genetics Laboratory. She graduated from the Manchester University, UK with a degree in Biochemistry in 1993 and completed a Ph.D. in Biochemistry in 1998 at the Institute of Child Health, University College London. She has worked at the Duke School of Medicine since 1999, completing a fellowship in Clinical Biochemical Genetics in 2005. Her main research interest is the development and application of biomarker assays for rare, inherited metabolic disorders that will improve diagnosis of these conditions, and are useful for monitoring treatments. This includes neurometabolic disorders such as the creatine deficiency syndromes. These disorders can be diagnosed using liquid chromatography-tandem mass spectrometric assays that measure biomarkers in urine and plasma. Additionally, more rapid methods have been developed using tandem mass spectrometry that can be used for newborn screening.
1993 Biochemistry B.Sc. (Hons) University of Manchester, U.K.
1998 Biochemistry Ph.D. University College London, U.K.
2005 ABMG certification in Clinical Biochemical Genetics
- El-Gharbawy A.H., Goldstein J.L., Millington D.S., Vaisnins A.E., Schlune A., Barshop B.A., Schulze A.,Koeberl D.D., Young S.P. (2013) Elevation of Guanidinoacetate in Newborn Dried Blood Spots and Impact of Early Treatment in GAMT Deficiency, Mol Genet Metab. 109:215-7.
- Manoli I, Sysol JR, Li L, Houillier P, Garone C, Wang C, Zerfas PM, Cusmano-Ozog K, Young S, Trivedi NS, Cheng J, Sloan JL, Chandler RJ, Abu-Asab M, Tsokos M, Elkahloun AG, Rosen S, Enns GM, Berry GT, Hoffmann V, DiMauro S, Schnermann J and Venditti CP (2013) Targeting proximal tubule mitochondrial dysfunction attenuates the renal disease of methylmalonic acidemia. . Proc Natl Acad Sci USA. 110:13552-7. doi: 10.1073/pnas.1302764110.
- Farah BL, Madden L, Li S, Nance S, Bird A, Bursac N, Yen PM, Young SP and Koeberl DD (2014) Adjunctive beta2-agonist treatment reduces glycogen independently of receptor-mediated acid alpha-glucosidase uptake in the limb muscles of mice with Pompe disease. FASEB J 28:2272-80.
- Koeberl DD, Austin S, Case LE, Smith EC, Buckley AF, Young SP, Bali D and Kishnani PS (2014) Adjunctive albuterol enhances the response to enzyme replacement therapy in late-onset Pompe disease. FASEB J 28:2171-6
- Houten SM, Denis S, te Brinke H, Jongejan A, van Kampen AHC, Bradley EJ, Baas F, Hennekam RCM, Millington DS, Young SP, Frazier DM, Gucsavas-Calikoglu M and Wanders RJA (2014) Mitochondrial NADP(H) deficiency due to a mutation in NADK2 causes dienoyl-CoA reductase deficiency with hyperlysinemia. Hum Mol Genet.23:5009-16.
- Zhang H, Wood T, Young SP, Millington DS. (2015) A straightforward, quantitative ultra-performance liquid chromatography-tandem mass spectrometric method for heparan sulfate, dermatan sulfate and chondroitin sulfate in urine: An improved clinical screening test for the mucopolysaccharidoses. Mol Genet Metab.114:123-8
- Prasun P, Young S, Salomons G, Werneke A, Jiang YH, Struys E, Paige M, Avantaggiati ML, McDonald M. (2015) Expanding the Clinical Spectrum of Mitochondrial Citrate Carrier (SLC25A1) Deficiency: Facial Dysmorphism in Siblings with Epileptic Encephalopathy and Combined D,L-2-Hydroxyglutaric Aciduria. JIMD Rep.19:111-5.
- Chien Y-Y, Goldstein JL, Hwu W-L, Smith PB, Lee NC, Chiang SC, Tolun AA, Zhang H, Vaisnins AE, Millington DS, Kishnani PS, Young SP. (2015) Baseline Urinary Glucose Tetrasaccharide Concentrations in Patients with Infantile and Late-Onset Pompe Disease Identified by Newborn Screening JIMD Rep.19:67-73.
- Nilsson MI, MacNeil LG, Kitaoka Y, Suri R, Young SP, Kaczor JJ, Nates NJ, Ansari MU, Wong T, Ahktar M, Brandt L, Hettinga BP, Tarnopolsky MA Combined aerobic exercise and enzyme replacement therapy rejuvenates the mitochondrial-lysosomal axis and alleviates autophagic blockage in Pompe disease. Free Radic Biol Med. 2015 May 19. pii: S0891-5849(15)00230-0. doi: 10.1016/j.freeradbiomed.2015.05.019. [Epub ahead of print]PMID: 26001726
SERN Lunch and Learn Announcement Wed, October 24th 2018
Please join us on
Wednesday, October 24that 12:00 pm (noon) at the
7th Floor Conference Room
Woodruff Memorial Research Building
101 Woodruff Circle
SERN Lunch and Learn Series.
A flyer is attached for your review.
Our speaker will be:
Allison Foley, MMSc, CGC
Certified Genetic Counselor
Lysosomal Storage Disease Center
Emory Department of Human Genetics
The title of her presentation is:
“Pompe Disease: Newborn Screening and Georgia Pilot Program Experience.”
Pizza will be provided
Please RSVP by Friday, October 19thto firstname.lastname@example.org
Live presentation via internet is available to a limited number of sites.
Email email@example.com for web reservations.